A Phase II, randomised trial of ONCOS-102 in combination with a checkpoint inhibitor and standard of care for mesothelioma
Latest Information Update: 25 Jun 2020
At a glance
- Drugs ONCOS 102 (Primary) ; Antineoplastics
- Indications Mesothelioma
- Focus Therapeutic Use
- 25 Jun 2020 New trial record
- 21 Jun 2020 According to a Targovax media release, the company plans to initiate the trial in collaboration with a pharma partner.